Minerva Neurosciences   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Cambridge MA United States (2007)

Organization Overview

First Clinical Trial
2014
NCT02232529
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Minerva Neurosciences